42 results on '"Reindl, Markus"'
Search Results
2. Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
3. New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseases
4. Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter
5. Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination
6. Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial
7. Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics
8. Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders
9. Natalizumab treatment reduces endothelial activity in MS patients
10. Features of intrathecal immunoglobulins in patients with multiple sclerosis
11. AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus
12. Multiple sclerosis: Disease biomarkers as indicated by pathophysiology
13. Antibodies as biological markers for pathophysiological processes in MS
14. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments
15. Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis
16. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders
17. Presence of anti-neuronal antibodies in children with neurological disorders beyond encephalitis.
18. Transient MOG antibody seroconversion associated with immunomodulating therapy
19. MR imaging in children with transverse myelitis and acquired demyelinating syndromes.
20. Investigating the Orexin/Hypocretin Specific T Cell Response in Patients with Narcolepsy with Cataplexy
21. Recurrent optic neuritis is characterised by anti-MOG antibodies: A follow-up study
22. Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres
23. A Highly Sensitive Live Cell Based Assay for Detection of Antibodies Against N-methyl-d-aspartate Receptors
24. Anti-myelin antibody responses following induction of antigen-specific tolerance with antigen-coupled cells
25. Increased serum levels of soluble CD14 indicate stable multiple sclerosis
26. Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern.
27. Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation
28. Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis
29. NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders.
30. The generation of NGF-secreting primary rat monocytes: A comparison of different transfer methods
31. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
32. The generation of NGF-secreting primary rat monocytes: A comparison of different transfer methods.
33. Animal models of multiple system atrophy
34. International MOGAD criteria.
35. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
36. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
37. A clinical approach to diagnosis of autoimmune encephalitis.
38. Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
39. Glial cell line-derived neurotrophic factor enhances survival of GM-CSF dependent rat GMIR1-microglial cells
40. Diagnostic features of initial demyelinating events associated with serum MOG-IgG.
41. IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome.
42. Endothelial progenitor cells, cardiovascular risk factors, cytokines levels and atherosclerosis-results from a large population-based study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.